Patents by Inventor Darrell Holton

Darrell Holton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190117779
    Abstract: A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy.
    Type: Application
    Filed: December 14, 2018
    Publication date: April 25, 2019
    Inventors: Darrell Holton, JR., Nelly Fransén, Matt Reddick
  • Publication number: 20180228204
    Abstract: The invention provides a smokeless tobacco product comprising a tobacco extract. In some embodiments, the smokeless tobacco product is translucent. The invention further provides methods for making and using the smokeless tobacco product. In certain embodiments, the smokeless tobacco product comprises isomalt, maltitol syrup, and a translucent tobacco extract prepared by ultrafiltration.
    Type: Application
    Filed: January 31, 2018
    Publication date: August 16, 2018
    Inventor: Darrell Holton, JR.
  • Patent number: 9907748
    Abstract: A composition intended to be employed for therapeutic purposes incorporates an active ingredient (e.g., a source of nicotine) and at a non-active ingredient that is carried by a porous substrate. The non-active ingredient can be a substance that has the capability of affecting the pH of the biological system to which it is applied (e.g., basic substance and/or buffering agent is sorbed onto the porous carrier, so as to be in intimate contact with that carrier). Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) and nicotine polacrilex. The basic substance can be sodium carbonate, and the porous substrate can be microcrystalline cellulose. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and can be used as a nicotine replacement therapy.
    Type: Grant
    Filed: October 21, 2011
    Date of Patent: March 6, 2018
    Assignee: Niconovum USA, Inc.
    Inventors: August Joseph Borschke, Darrell Holton, Jr.
  • Patent number: 9901113
    Abstract: The invention provides a smokeless tobacco product comprising a tobacco extract. In some embodiments, the smokeless tobacco product is translucent. The invention further provides methods for making and using the smokeless tobacco product. In certain embodiments, the smokeless tobacco product comprises isomalt, maltitol syrup, and a translucent tobacco extract prepared by ultrafiltration.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: February 27, 2018
    Assignee: R.J. Reynolds Tobacco Company
    Inventor: Darrell Holton, Jr.
  • Patent number: 9474303
    Abstract: A smokeless tobacco product is provided that includes a tobacco material in the form of a tobacco extract, a particulate tobacco material, or a combination thereof. In some embodiments, the smokeless tobacco product is substantially translucent. Methods for making and using the smokeless tobacco product are also provided. The smokeless tobacco product can include isomalt, maltitol syrup, particulate tobacco, and a translucent tobacco extract prepared by ultrafiltration.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: October 25, 2016
    Assignee: R.J. Reynolds Tobacco Company
    Inventor: Darrell Holton, Jr.
  • Publication number: 20150296871
    Abstract: The invention provides a smokeless tobacco product comprising a tobacco extract. In some embodiments, the smokeless tobacco product is translucent. The invention further provides methods for making and using the smokeless tobacco product. In certain embodiments, the smokeless tobacco product comprises isomalt, maltitol syrup, and a translucent tobacco extract prepared by ultrafiltration.
    Type: Application
    Filed: July 1, 2015
    Publication date: October 22, 2015
    Inventor: Darrell Holton, Jr.
  • Patent number: 9084439
    Abstract: The invention provides a smokeless tobacco product comprising a tobacco extract. In some embodiments, the smokeless tobacco product is translucent. The invention further provides methods for making and using the smokeless tobacco product. In certain embodiments, the smokeless tobacco product comprises isomalt, maltitol syrup, and a translucent tobacco extract prepared by ultrafiltration.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: July 21, 2015
    Assignee: R.J. Reynolds Tobacco Company
    Inventor: Darrell Holton, Jr.
  • Publication number: 20150071972
    Abstract: A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy.
    Type: Application
    Filed: November 13, 2014
    Publication date: March 12, 2015
    Inventors: Darrell Holton, JR., Nelly Fransén, Matt Reddick
  • Publication number: 20130098377
    Abstract: A composition intended to be employed for therapeutic purposes incorporates an active ingredient (e.g., a source of nicotine) and at a non-active ingredient that is carried by a porous substrate. The non-active ingredient can be a substance that has the capability of affecting the pH of the biological system to which it is applied (e.g., basic substance and/or buffering agent is sorbed onto the porous carrier, so as to be in intimate contact with that carrier). Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) and nicotine polacrilex. The basic substance can be sodium carbonate, and the porous substrate can be microcrystalline cellulose. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and can be used as a nicotine replacement therapy.
    Type: Application
    Filed: October 21, 2011
    Publication date: April 25, 2013
    Inventors: August Joseph Borschke, Darrell Holton, JR.
  • Publication number: 20130074856
    Abstract: A smokeless tobacco product is provided that includes a tobacco material in the form of a tobacco extract, a particulate tobacco material, or a combination thereof. In some embodiments, the smokeless tobacco product is substantially translucent. Methods for making and using the smokeless tobacco product are also provided. The smokeless tobacco product can include isomalt, maltitol syrup, particulate tobacco, and a translucent tobacco extract prepared by ultrafiltration.
    Type: Application
    Filed: September 13, 2012
    Publication date: March 28, 2013
    Inventor: Darrell Holton, JR.
  • Publication number: 20130074855
    Abstract: The invention provides a smokeless tobacco product comprising a tobacco extract. In some embodiments, the smokeless tobacco product is translucent. The invention further provides methods for making and using the smokeless tobacco product. In certain embodiments, the smokeless tobacco product comprises isomalt, maltitol syrup, and a translucent tobacco extract prepared by ultrafiltration.
    Type: Application
    Filed: September 22, 2011
    Publication date: March 28, 2013
    Inventor: Darrell Holton, JR.
  • Publication number: 20130078307
    Abstract: A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy.
    Type: Application
    Filed: September 22, 2011
    Publication date: March 28, 2013
    Inventors: Darrell Holton, JR., Nelly Fransen, Matt Reddick
  • Publication number: 20080029110
    Abstract: A smokeless tobacco product configured for insertion into the mouth of a user of the product is provided, the tobacco product including a water-permeable pouch containing a tobacco formulation, the tobacco formulation including a tobacco material and a plurality of microcapsules dispersed within the tobacco material, the plurality of microcapsules including an outer shell encapsulating an internal payload. The internal payload may include an additive such as water, flavorants, binders, colorants, pH adjusters, buffering agents, fillers, disintegration aids, humectants, antioxidants, oral care ingredients, preservatives, additives derived from herbal or botanical sources, and mixtures thereof. Microencapsulated flavorants include tobacco-containing flavorants, such as tobacco extracts or a particulate tobacco material, sweeteners (e.g., sweeteners containing neotame), and vanillin (optionally in a complexed form).
    Type: Application
    Filed: July 23, 2007
    Publication date: February 7, 2008
    Inventors: Michael Dube, Daniel Cantrell, John-Paul Mua, Darrell Holton, Cynthia Stokes, James Figlar
  • Publication number: 20070186941
    Abstract: A smokeless tobacco product includes a powdered or granular smokeless tobacco formulation that is contained within a moisture-permeable packet or pouch. The smokeless tobacco formulation may include finely ground particles of tobacco in powder-like form and other ingredients such as sweeteners, binders, colorants, pH adjusters, fillers, flavoring ingredients, disintegration aids, antioxidants and preservatives. The tobacco formulation may have a dry or moist form. The container has the form of a pouch or bag, such as is the type commonly used for the manufacture of snus products. The container preferably contains at least one capsule, such as a spherical breakable capsule. The container is intended to be placed in the mouth of the tobacco user, such that the tobacco formulation within the container may be enjoyed by the user. After the tobacco user is finished using the smokeless tobacco product, the container is removed from the user's mouth for disposal.
    Type: Application
    Filed: February 10, 2006
    Publication date: August 16, 2007
    Inventors: Darrell Holton, Daniel Cantrell
  • Publication number: 20070062549
    Abstract: A smokeless tobacco product includes a powdered or granular smokeless tobacco formulation that is contained within a moisture-permeable packet or pouch. The smokeless tobacco formulation includes finely ground particles of tobacco in powder-like form and other ingredients such as sweeteners, binders, colorants, pH adjusters, fillers, flavoring agents, disintegration aids, antioxidants and preservatives. The container has the form of a pouch or bag, such as is the type commonly for the manufacture of snus products. The container is intended to be placed in the mouth of the tobacco user, in order that the dry tobacco formulation within the container may be enjoyed by the user. After the tobacco user is finished using the smokeless tobacco product, the container is removed from the user's mouth for disposal. Alternatively, the container is dissolvable or dispersible in the mouth of the user.
    Type: Application
    Filed: September 22, 2005
    Publication date: March 22, 2007
    Inventors: Darrell Holton, Daniel Cantrell, James Figlar